StageZero Life Sciences (TSX:SZLS) PB Ratio : (As of Apr. 27, 2024)

View and export this data going back to 2001. Start your Free Trial

What is StageZero Life Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-27), StageZero Life Sciences's share price is C$0.04. StageZero Life Sciences's Book Value per Share for the quarter that ended in Sep. 2023 was C$-0.10. Hence, StageZero Life Sciences's PB Ratio of today is .

The historical rank and industry rank for StageZero Life Sciences's PB Ratio or its related term are showing as below:

During the past 13 years, StageZero Life Sciences's highest PB Ratio was 149.87. The lowest was 2.22. And the median was 9.00.

TSX:SZLS's PB Ratio is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.055
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, StageZero Life Sciences's average Book Value Per Share Growth Rate was -626.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 17.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of StageZero Life Sciences was 94.10% per year. The lowest was -54.60% per year. And the median was 1.35% per year.

Back to Basics: PB Ratio

StageZero Life Sciences PB Ratio Historical Data

The historical data trend for StageZero Life Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StageZero Life Sciences PB Ratio Chart

StageZero Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PB Ratio

Get a 7-Day Free Trial

7.56

StageZero Life Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
PB Ratio	Get a 7-Day Free Trial															4.21	-	-	-	-

Competitive Comparison of StageZero Life Sciences's PB Ratio

For the Diagnostics & Research subindustry, StageZero Life Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StageZero Life Sciences's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, StageZero Life Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where StageZero Life Sciences's PB Ratio falls into.

StageZero Life Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

StageZero Life Sciences's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Sep. 2023)
	=	0.04	/	-0.1
	=

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

StageZero Life Sciences (TSX:SZLS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

StageZero Life Sciences PB Ratio Related Terms

Thank you for viewing the detailed overview of StageZero Life Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

StageZero Life Sciences (TSX:SZLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » StageZero Life Sciences Ltd (TSX:SZLS) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

SZLSF:USA 61N1:Germany

Address

70 East Beaver Creek Road, Unit 30, Richmond Hill, ON, CAN, L4B 3B2

Website

https://www.stagezerolifesciences.com

StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.

StageZero Life Sciences (TSX:SZLS) Headlines

No Headlines